BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 25367850)

  • 1. Pokemon enhances proliferation, cell cycle progression and anti-apoptosis activity of colorectal cancer independently of p14ARF-MDM2-p53 pathway.
    Zhao Y; Yao YH; Li L; An WF; Chen HZ; Sun LP; Kang HX; Wang S; Hu XR
    Med Oncol; 2014 Dec; 31(12):288. PubMed ID: 25367850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 gene status and expression of p53, MDM2, and p14 proteins in ameloblastomas.
    Kumamoto H; Izutsu T; Ohki K; Takahashi N; Ooya K
    J Oral Pathol Med; 2004 May; 33(5):292-9. PubMed ID: 15078490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p14(ARF) regulates E2F activity.
    Mason SL; Loughran O; La Thangue NB
    Oncogene; 2002 Jun; 21(27):4220-30. PubMed ID: 12082609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of proteins in p53 (p14ARF-mdm2-p53-p21WAF/CIP1) pathway and their significance in exocrine pancreatic carcinoma].
    Yu GZ; Zhu MH; Ni CR; Li FM; Zheng JM; Gong ZJ
    Zhonghua Bing Li Xue Za Zhi; 2004 Apr; 33(2):130-4. PubMed ID: 15132849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different trends of p53, MDM2 and p14 ARF expression patterns in endometrial adenocarcinomas versus hyperplasia.
    Buchynska LG; Nesina IP; Kashuba EV
    Exp Oncol; 2007 Dec; 29(4):287-94. PubMed ID: 18199985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
    Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
    Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological significance of promoter hypermethylation of p14/ARF gene: relationships to p53 mutational status in Tunisian population with colorectal carcinoma.
    Chaar I; Amara S; Elamine OE; Khiari M; Ounissi D; Khalfallah T; Ben Hmida A; Mzabi S; Bouraoui S
    Tumour Biol; 2014 Feb; 35(2):1439-49. PubMed ID: 24065196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of p53, MDM2 and p14(ARF) protein expression in human esophageal squamous cell carcinoma.
    Cheng TH; Hsu PK; Li AF; Hung IC; Huang MH; Hsu HS
    J Cancer Res Clin Oncol; 2009 Nov; 135(11):1577-82. PubMed ID: 19488782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlations of partial and extensive methylation at the p14(ARF) locus with reduced mRNA expression in colorectal cancer cell lines and clinicopathological features in primary tumors.
    Zheng S; Chen P; McMillan A; Lafuente A; Lafuente MJ; Ballesta A; Trias M; Wiencke JK
    Carcinogenesis; 2000 Nov; 21(11):2057-64. PubMed ID: 11062168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2.
    Stott FJ; Bates S; James MC; McConnell BB; Starborg M; Brookes S; Palmero I; Ryan K; Hara E; Vousden KH; Peters G
    EMBO J; 1998 Sep; 17(17):5001-14. PubMed ID: 9724636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of p14ARF, MDM2, and MDM4 in human retinoblastoma.
    Guo Y; Pajovic S; Gallie BL
    Biochem Biophys Res Commun; 2008 Oct; 375(1):1-5. PubMed ID: 18644346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased frequency of aberrations in the p53/MDM2/p14(ARF) pathway in neuroblastoma cell lines established at relapse.
    Carr J; Bell E; Pearson AD; Kees UR; Beris H; Lunec J; Tweddle DA
    Cancer Res; 2006 Feb; 66(4):2138-45. PubMed ID: 16489014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncomir miR-125b suppresses p14(ARF) to modulate p53-dependent and p53-independent apoptosis in prostate cancer.
    Amir S; Ma AH; Shi XB; Xue L; Kung HJ; Devere White RW
    PLoS One; 2013; 8(4):e61064. PubMed ID: 23585871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low p14ARF expression in neuroblastoma cells is associated with repressed histone mark status, and enforced expression induces growth arrest and apoptosis.
    Dreidax D; Gogolin S; Schroeder C; Muth D; Brueckner LM; Hess EM; Zapatka M; Theißen J; Fischer M; Ehemann V; Schwab M; Savelyeva L; Westermann F
    Hum Mol Genet; 2013 May; 22(9):1735-45. PubMed ID: 23343716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of p21 disrupts p14 ARF-induced G1 cell cycle arrest but augments p14 ARF-induced apoptosis in human carcinoma cells.
    Hemmati PG; Normand G; Verdoodt B; von Haefen C; Hasenjäger A; Güner D; Wendt J; Dörken B; Daniel PT
    Oncogene; 2005 Jun; 24(25):4114-28. PubMed ID: 15750619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of CCDC69 activates p14
    Cui L; Zhou F; Chen C; Wang CC
    J Ovarian Res; 2019 Jan; 12(1):4. PubMed ID: 30651135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene amplification is a relatively frequent event leading to ZBTB7A (Pokemon) overexpression in non-small cell lung cancer.
    Apostolopoulou K; Pateras IS; Evangelou K; Tsantoulis PK; Liontos M; Kittas C; Tiniakos DG; Kotsinas A; Cordon-Cardo C; Gorgoulis VG
    J Pathol; 2007 Nov; 213(3):294-302. PubMed ID: 17907153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epithelial cell-derived periostin functions as a tumor suppressor in gastric cancer through stabilizing p53 and E-cadherin proteins via the Rb/E2F1/p14ARF/Mdm2 signaling pathway.
    Lv H; Liu R; Fu J; Yang Q; Shi J; Chen P; Ji M; Shi B; Hou P
    Cell Cycle; 2014; 13(18):2962-74. PubMed ID: 25486483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Azidothymidine and cisplatin increase p14ARF expression in OVCAR-3 ovarian cancer cell line.
    Vaskivuo L; Rysä J; Koivuperä J; Myllynen P; Vaskivuo T; Chvalova K; Serpi R; Savolainen ER; Puistola U; Vähäkangas K
    Toxicol Appl Pharmacol; 2006 Oct; 216(1):89-97. PubMed ID: 16797627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of apoptosis in human esophageal cancer cells by sequential transfer of the wild-type p53 and E2F-1 genes: involvement of p53 accumulation via ARF-mediated MDM2 down-regulation.
    Itoshima T; Fujiwara T; Waku T; Shao J; Kataoka M; Yarbrough WG; Liu TJ; Roth JA; Tanaka N; Kodama M
    Clin Cancer Res; 2000 Jul; 6(7):2851-9. PubMed ID: 10914734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.